JP2008530242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530242A5 JP2008530242A5 JP2007556366A JP2007556366A JP2008530242A5 JP 2008530242 A5 JP2008530242 A5 JP 2008530242A5 JP 2007556366 A JP2007556366 A JP 2007556366A JP 2007556366 A JP2007556366 A JP 2007556366A JP 2008530242 A5 JP2008530242 A5 JP 2008530242A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- alkyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN347DE2005 | 2005-02-17 | ||
| IN347/DEL/2005 | 2005-02-17 | ||
| US11/096,718 US7521465B2 (en) | 2003-01-17 | 2005-03-31 | Diphenyl ether derivatives |
| US11/096,718 | 2005-03-31 | ||
| PCT/US2006/005846 WO2006089225A1 (en) | 2005-02-17 | 2006-02-17 | 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2 , 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008530242A JP2008530242A (ja) | 2008-08-07 |
| JP2008530242A5 true JP2008530242A5 (enExample) | 2009-04-16 |
| JP5134974B2 JP5134974B2 (ja) | 2013-01-30 |
Family
ID=36570583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007556366A Expired - Fee Related JP5134974B2 (ja) | 2005-02-17 | 2006-02-17 | 血漿中のグルコースレベル、コレステロールレベル及びトリグリセリドレベルを低下させるための５−［４−（４−（２−アミノ−２−メトキシカルボニルエチル）フェノキシ）ベンジリデン］チアゾリジン−２，４−ジオン誘導体及び関連化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7521465B2 (enExample) |
| EP (1) | EP1848700B1 (enExample) |
| JP (1) | JP5134974B2 (enExample) |
| KR (1) | KR20070105364A (enExample) |
| CA (1) | CA2598087C (enExample) |
| ES (1) | ES2566337T3 (enExample) |
| HU (1) | HUE028882T2 (enExample) |
| PL (1) | PL1848700T3 (enExample) |
| WO (1) | WO2006089225A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9969980B2 (en) * | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US9969977B2 (en) * | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US7521465B2 (en) | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
| US7781464B2 (en) | 2003-01-17 | 2010-08-24 | Bexel Pharmaceuticals, Inc. | Heterocyclic diphenyl ethers |
| US7087576B2 (en) * | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
| KR100814109B1 (ko) * | 2006-01-09 | 2008-03-14 | 한국생명공학연구원 | 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물 |
| EP2066800A2 (en) * | 2006-08-04 | 2009-06-10 | Decode Genetics EHF | Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation |
| US20090069313A1 (en) * | 2007-09-06 | 2009-03-12 | Orchid Research Laboratories Ltd. | Novel MAO-A inhibitors |
| CN102036974B (zh) | 2008-05-20 | 2014-07-23 | 默沙东公司 | 利用甘露糖基转移酶抑制剂有效生产异源蛋白质 |
| CA2805245A1 (en) * | 2010-07-28 | 2012-02-02 | Orchid Research Laboratories Ltd. | Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases |
| JP6014816B2 (ja) | 2011-05-10 | 2016-10-26 | 国立大学法人神戸大学 | Ｒａｓ機能阻害作用を有するチオキソチアゾリジン誘導体 |
| EP4029859A1 (en) * | 2014-11-21 | 2022-07-20 | Bsim Therapeutics, S.A. | 2-oxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof |
| TW202019923A (zh) * | 2018-07-16 | 2020-06-01 | 義大利商吉斯藥品公司 | 作為Ｒｈｏ－激酶抑制劑之酪胺酸醯胺衍生物 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0228168A (ja) * | 1988-04-14 | 1990-01-30 | Sankyo Co Ltd | チアゾール誘導体 |
| US20020049240A1 (en) | 1994-12-19 | 2002-04-25 | Beecham Group P.1.C. | Novel compounds |
| US5166137A (en) | 1991-03-27 | 1992-11-24 | Nobipols Forskningsstiftelse | Guluronic acid polymers and use of same for inhibition of cytokine production |
| US5441971A (en) | 1991-04-11 | 1995-08-15 | The Upjohn Company | Thiazolidinedione derivatives, production and use thereof |
| TW268952B (enExample) | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
| US5527546A (en) | 1994-08-10 | 1996-06-18 | Bayer Corporation | Human interleukin 6 inhibitor |
| ES2220929T3 (es) | 1995-05-11 | 2004-12-16 | Applied Research Systems Ars Holding N.V. | Inhibidor de la actividad il-6. |
| TW577875B (en) | 1997-01-31 | 2004-03-01 | Shionogi & Co | Pyrrolidine derivatives with inhibitory activity for phospholipase A2 |
| US6331633B1 (en) | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6699896B1 (en) | 1998-05-12 | 2004-03-02 | Wyeth | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| CN1311787A (zh) | 1998-06-05 | 2001-09-05 | 阿斯特拉曾尼卡有限公司 | 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物 |
| AU4713499A (en) | 1998-06-27 | 2000-01-17 | Photogenesis, Inc. | Ophthalmic uses of ppargamma agonists and ppargamma antagonists |
| KR100613175B1 (ko) | 1998-08-27 | 2006-08-17 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 유도체 및 그 유도체를 유효 성분으로서함유하는 약제 |
| ID30498A (id) | 1999-04-07 | 2001-12-13 | Sankyo Co | Senyawa-senyawa turunan amina |
| EP1177187B1 (en) | 1999-04-28 | 2007-07-25 | Sanofi-Aventis Deutschland GmbH | Di-aryl acid derivatives as ppar receptor ligands |
| TWI284533B (en) | 1999-05-24 | 2007-08-01 | Sankyo Co | Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant |
| CN1321153A (zh) | 1999-07-01 | 2001-11-07 | 杰龙公司 | 端粒酶抑制剂及其使用方法 |
| KR100738245B1 (ko) | 1999-08-23 | 2007-07-12 | 교린 세이야꾸 가부시키 가이샤 | 치환된 벤질티아졸리딘-2,4-디온 유도체 |
| CA2383347A1 (en) | 1999-08-31 | 2001-03-08 | Maxia Pharmaceuticals, Inc. | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| JP2001199888A (ja) | 2000-01-24 | 2001-07-24 | Fujimoto Brothers:Kk | 糖尿病治療剤 |
| JP2001308814A (ja) | 2000-04-19 | 2001-11-02 | Hitachi Ltd | フレーム構成自動識別通信装置 |
| ES2248242T3 (es) | 2000-04-21 | 2006-03-16 | Pfizer Products Inc. | Ligandos de receptores tiroideos. |
| US6620830B2 (en) | 2000-04-21 | 2003-09-16 | Pfizer, Inc. | Thyroid receptor ligands |
| US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6525202B2 (en) * | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| HUP0401492A3 (en) | 2001-09-14 | 2008-05-28 | Novo Nordisk As | Novel ligands for the hisb10 zn2+ sites of r-state insulin hexa |
| JP2005513026A (ja) * | 2001-11-15 | 2005-05-12 | インサイト サン ディエゴ インコーポレイテッド | 高コレステロール血症、異脂肪血症および他の代謝障害；癌、および他の疾患を治療するｎ−置換複素環 |
| US7521465B2 (en) | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
| US6794401B2 (en) | 2003-01-17 | 2004-09-21 | Bexel Pharmaceuticals, Inc. | Amino acid phenoxy ethers |
| EP1610812A1 (en) | 2003-03-11 | 2006-01-04 | Novo Nordisk A/S | Pharmaceutical preparations comprising acid-stabilised insulin |
| US7087576B2 (en) | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
-
2005
- 2005-03-31 US US11/096,718 patent/US7521465B2/en not_active Expired - Fee Related
-
2006
- 2006-02-17 KR KR1020077021343A patent/KR20070105364A/ko not_active Ceased
- 2006-02-17 WO PCT/US2006/005846 patent/WO2006089225A1/en not_active Ceased
- 2006-02-17 PL PL06735487T patent/PL1848700T3/pl unknown
- 2006-02-17 CA CA2598087A patent/CA2598087C/en not_active Expired - Fee Related
- 2006-02-17 EP EP06735487.8A patent/EP1848700B1/en not_active Expired - Lifetime
- 2006-02-17 ES ES06735487.8T patent/ES2566337T3/es not_active Expired - Lifetime
- 2006-02-17 JP JP2007556366A patent/JP5134974B2/ja not_active Expired - Fee Related
- 2006-02-17 HU HUE06735487A patent/HUE028882T2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102084109B1 (ko) | 캡 의존적 엔도뉴클레아제 저해제 및 항인플루엔자 약을 조합하는 것을 특징으로 하는 인플루엔자 치료용 의약 | |
| JP6553059B2 (ja) | Ｈｂｖ感染の治療のための併用療法 | |
| JP2019069941A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| RU2006105717A (ru) | Производные пиперазина и их применение в качестве терапевтических агентов | |
| JP2008530242A5 (enExample) | ||
| WO1993022298A1 (fr) | Derive d'oxazolidine et son sel pharmaceutiquement acceptable | |
| TW200522941A (en) | Method for modulating calcium ion-release-activated calcium ion channels | |
| JP2008513515A5 (enExample) | ||
| JP2008513498A5 (enExample) | ||
| JP2009528997A5 (enExample) | ||
| JP5539978B2 (ja) | チアゾピリミジノンおよびその使用 | |
| IL287159B1 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| JP2011516511A5 (enExample) | ||
| RU2007108863A (ru) | Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3 | |
| JP2024515062A (ja) | 重水素化ｄｈｏｄｈ阻害剤 | |
| JP2004529145A5 (enExample) | ||
| RU2007108415A (ru) | Новое циклическое производное аминобензойной кислоты | |
| KR100718906B1 (ko) | 디히드로나프탈렌 유도체 화합물 및 이 화합물을 유효성분으로 하는 약제 | |
| RU2006138426A (ru) | Производные тиазолопиридина, содержащие их фармацевтические композиции и способы лечения состояний, опосредованных глюкокиназой | |
| JP2004525183A5 (enExample) | ||
| JP5890064B2 (ja) | ４−（（置換フェニル）ジフルオロメチル）フェノキシカルボン酸誘導体およびその調製方法およびその使用 | |
| JP2020520949A5 (enExample) | ||
| ES2642172T3 (es) | Compuestos derivados de ciclohexeno sustituidos con biarilo o biarilo heterocíclico como inhibidores de CETP | |
| WO2015102369A1 (ko) | 1,2 나프토퀴논 유도체 및 이의 제조방법 | |
| ES2390053T3 (es) | Derivado de ácido fenilacético, procedimiento para producir el mismo y uso |